Results 191 to 200 of about 19,143 (231)

Pharmacokinetics and Pharmacodynamics of Nipocalimab, a Neonatal Fc Receptor Blocker, in Healthy Japanese Volunteers. [PDF]

Clin Drug Investig
Matsushima N, Shibata S, Leu JH, Vermeulen A, Duffner J, Ling LE, Schwartz LB, Harigae H.   +7 more
europepmc   +1 more source

Podocyte-specific knockout of the neonatal Fc receptor (FcRn) results in differential protection depending on the model of glomerulonephritis. [PDF]

PLoS One, 2020
Dylewski JF, Tonsawan P, Garcia G, Lewis L, Blaine J.   +4 more
europepmc   +1 more source

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Neonatal Fc Receptor Inhibitor Rozanolixizumab: An Ethnic Sensitivity Study in Healthy Japanese, Chinese, and White Participants. [PDF]

Clin Pharmacol Drug Dev
El Baghdady A, Lledó-García R, Gayfieva M, Lowcock R, Watanabe S, Sidhu J, Wilkes D.   +6 more
europepmc   +1 more source

Quality of Life in Chronic Heart Failure With Obstructive Sleep Apnea: A Systematic Review

Nursing Open, Volume 12, Issue 12, December 2025.
ABSTRACT Aim To describe the quality of life in patients with chronic heart failure and coexisting obstructive sleep apnoea, and to examine the effect of common sleep‐disordered breathing treatments on quality of life, functional capacity and cardiac outcomes. Design Systematic review.
Francesco Limonti, Giovanni Cangelosi, Diaratou Dabre, Gianluca Marino, Arcangelo Correra, Sara Morales Palomares, Nicola Ramacciati, Francesco Gravante   +7 more
wiley   +1 more source

Outpatient or Inpatient Setting for Cervical Ripening Before Induction of Labour: An Individual Participant Data Meta‐Analysis

BJOG: An International Journal of Obstetrics &Gynaecology, Volume 132, Issue 13, Page 1966-1982, December 2025.
ABSTRACT Background The optimal methods and settings for induction of labour (IOL) in terms of effectiveness, safety, and women's experience are still not elucidated. Objective To compare the effectiveness and safety of outpatient versus inpatient cervical ripening settings for IOL. Search Strategy MEDLINE, Embase, Emcare, CINAHL Plus, Scopus, Cochrane
Malitha Patabendige, Fei Chan, Michelle R. Wise, John M. D. Thompson, Michael Beckmann, Antonio F. Saad, George R. Saade, Akila Subramaniam, Alan Tita, Catarina Policiano, Nuno Clode, Amanda Henry, Henna Haavisto, Kirsi Rinne, Vicky Chen, Penelope Sheehan, Katherine Kohari, Hillary Hosier, Rebecca Pierce‐Williams, Vincenzo Berghella, Daniel L. Rolnik, Ben W. Mol, Wentao Li   +22 more
wiley   +1 more source

Elevated Serum Bile Acids Predict Poor Liver Outcomes in Children With Alagille Syndrome: Results From the GALA Study Group

Liver International, Volume 45, Issue 12, December 2025.
ABSTRACT Background and Aim Alagille syndrome (ALGS) is a rare disorder characterised by cholestasis and extrahepatic manifestations. Given the current era of ileal bile acid transporter (IBAT) inhibitor therapies that reduce serum bile acid (SBA) levels, we evaluated whether SBA predicts liver disease outcomes in ALGS.
Carla Fiorella Murillo Perez, Shannon M. Vandriel, Emmanuel M. Gonzales, Jian‐She Wang, Li‐Ting Li, Huiyu She, Irena Jankowska, Piotr Czubkowski, Dorota Gliwicz‐Miedzińska, Emmanuel Jacquemin, Jérôme Bouligand, Lorenzo D'Antiga, Emanuele Nicastro, Björn Fischler, Henrik Arnell, Susan M. Siew, Michael Stormon, Kathleen M. Loomes, David A. Piccoli, Elizabeth B. Rand, James E. Squires, Saul J. Karpen, Rene Romero, Mureo Kasahara, Zerrin Önal, Étienne Sokal, Tanguy Demaret, Sabina Wiecek, Florence Lacaille, Dominique Debray, Winita Hardikar, Sahana Shankar, Pamela L. Valentino, Shikha S. Sundaram, Noelle H. Ebel, Jeffrey A. Feinstein, Orith Waisbourd‐Zinman, Henry C. Lin, Nathalie Rock, Henkjan J. Verkade, M. Kyle Jensen, Catalina Jaramillo, Kyung Mo Kim, Seak Hee Oh, Jernej Brecemiclj, Seema Alam, Giuseppe Indolfi, Niviann Blondet, Rima Fawaz, Silvia Nastasio, Pier Luigi Calvo, Gabriella Nebbia, Cigdem Arikan, Catherine Larson‐Nath, Andréanne N. Zizzo, Thomas Damgaard Sandahl, Christos Tzivinikos, Nehal M. El‐Koofy, Mohamed A. Elmonem, Amal A. Aqul, Wikrom Karnsakul, Pinar Bulut, Nanda Kerkar, Victorien M. Wolters, Amin J. Roberts, Helen M. Evans, Maria Camila Sanchez, Maria Lorena Cavalieri, Deirdre A. Kelly, Jane Hartley, Way Seah Lee, Christina Hajinicolaou, Chatmanee Lertudomphonwanit, Ryan T. Fischer, Jesus Quintero Bernabeu, Ruben E. Quiros‐Tejeira, Cristina Targa Ferreira, Elisa Carvalho, John Eshun, Aglaia Zellos, Antal Dezsőfi, Raquel Borges Pinto, Kathleen Schwarz, Maria Rogalidou, Jennifer Garcia, María Legarda Tamara, Marisa Beretta, Quais Mujawar, Ermelinda Santos‐Silva, Cristina Molera Busoms, Eberhard Lurz, Cristina Gonçalves, Carolina Jimenez‐Rivera, Jesus M. Banales, Richard J. Thompson, Bettina E. Hansen, Binita M. Kamath, The Global ALagille Alliance (GALA) Study Group   +97 more
wiley   +1 more source

Reducing neonatal Fc receptor binding enhances clearance and brain-to-blood ratio of TfR-delivered bispecific amyloid-β antibody. [PDF]

MAbs
Schlein E, Andersson KG, Dallas T, Syvänen S, Sehlin D.   +4 more
europepmc   +1 more source

Treatment with anti-neonatal Fc receptor (FcRn) antibody ameliorates experimental epidermolysis bullosa acquisita in mice. [PDF]

Br J Pharmacol, 2020
Kasprick A, Hofrichter M, Smith B, Ward P, Bieber K, Shock A, Ludwig RJ, Schmidt E.   +7 more
europepmc   +1 more source

Randomised controlled field trial to assess the safety and efficacy of a killed autologous vaccine against Streptococcus dysgalactiae subspecies dysgalactiae in a sheep flock

Veterinary Record, Volume 197, Issue 10, Page e256-e263, 15/22 November 2025.
Abstract Introduction Joint‐ill in neonatal lambs, primarily caused by Streptococcus dysgalactiae subspecies dysgalactiae (SDSD), results in increased mortality and morbidity. An effective vaccine is needed to prevent the disease. Methods A blinded randomised controlled trial was carried out using an autologous SDSD vaccine in a commercial sheep flock ...
Joseph W. Angell, Naseem Ahmed, Louise P. Jackson, Konstantina Kasiora, Keith Ballingall, Jennifer S. Duncan   +5 more
wiley   +1 more source

Association of the neonatal Fc receptor promoter variable number of tandem repeat polymorphism with immunoglobulin response in patients with chronic inflammatory demyelinating polyneuropathy. [PDF]

Eur J Neurol
Fisse AL, Schäfer E, Hieke A, Schröder M, Klimas R, Brünger J, Huckemann S, Grüter T, Sgodzai M, Schneider-Gold C, Gold R, Nguyen HP, Pitarokoili K, Motte J, Arning L.   +14 more
europepmc   +1 more source